AbbVie, U of C Choose First Batch of Cancer Research Projects
Pharmaceutical giant AbbVie and University of Chicago have picked their initial set of projects to research cancer, a deadly disease given a renewed focus under the Obama administration. They include a new immunotherapy that could essentially weaponize a person’s immune… Keep reading